Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients.

Arnaoutakis GJ, Allen JG, Merlo CA, Baumgartner WA, Conte JV, Shah AS.

J Heart Lung Transplant. 2010 Dec;29(12):1380-7. doi: 10.1016/j.healun.2010.05.031.

2.

Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation.

George TJ, Arnaoutakis GJ, Baumgartner WA, Shah AS, Conte JV.

J Heart Lung Transplant. 2011 Sep;30(9):1033-43. doi: 10.1016/j.healun.2011.05.005.

PMID:
21683620
3.

In vivo measurement of lung preservation solution efficacy: comparison of LPD, UW, EC and low K+-EC following short and extended ischemia.

Hausen B, Beuke M, Schroeder F, Poets CF, Hewitt C, DelRossi AJ, Schäfers HJ.

Eur J Cardiothorac Surg. 1997 Nov;12(5):771-9; discussion 779-80.

PMID:
9458150
4.

Low-potassium UW solution for lung preservation. Comparison with regular UW, LPD, and Euro-Collins solutions.

Oka T, Puskas JD, Mayer E, Cardoso PF, Shi SQ, Wisser W, Slutsky AS, Patterson GA.

Transplantation. 1991 Dec;52(6):984-8.

PMID:
1721252
5.

The superiority of UW solution for maintaining ATP concentrations during pulmonary preservation.

Omote Y, Ikeda K, Yamazaki K, Kubo Y.

Surg Today. 1994;24(7):616-20.

PMID:
7524829
6.

Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group.

Porte RJ, Ploeg RJ, Hansen B, van Bockel JH, Thorogood J, Persijn GG, Hermans J, Terpstra OT.

Transpl Int. 1998;11 Suppl 1:S164-7.

7.

Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.

Pirenne J, Van Gelder F, Coosemans W, Aerts R, Gunson B, Koshiba T, Fourneau I, Mirza D, Van Steenbergen W, Fevery J, Nevens F, McMaster P.

Liver Transpl. 2001 Jun;7(6):540-5.

8.

[Preservation of kidney transplants with a modified UW solution--initial clinical results].

Schlumpf R, Candinas D, Weber M, Röthlin M, Largiadèr F.

Swiss Surg. 1995;(4):175-80; discussion 180-1. German.

PMID:
9156817
9.

Late retrograde perfusion of donor lungs does not decrease the severity of primary graft dysfunction.

Ferraro P, Martin J, Dery J, Prenovault J, Samson L, Coutu M, Chen LQ, Poirier C, Noiseux N, Duranceau A, Berthiaume Y.

Ann Thorac Surg. 2008 Oct;86(4):1123-9. doi: 10.1016/j.athoracsur.2008.05.048.

PMID:
18805145
10.

Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study.

Boggi U, Vistoli F, Del Chiaro M, Signori S, Croce C, Pietrabissa A, Berchiolli R, Marchetti P, Del Prato S, Mosca F.

Transplantation. 2004 Apr 27;77(8):1186-90.

PMID:
15114082
11.

Superior protection in orthotopic rat lung transplantation with cyclic adenosine monophosphate and nitroglycerin-containing preservation solution.

Kayano K, Toda K, Naka Y, Okada K, Oz MC, Pinsky DJ.

J Thorac Cardiovasc Surg. 1999 Jul;118(1):135-44.

12.

Impact of initial flush potassium concentration on the adequacy of lung preservation.

Sasaki S, McCully JD, Alessandrini F, LoCicero J 3rd.

J Thorac Cardiovasc Surg. 1995 Jun;109(6):1090-5; discussion 1095-6.

13.

A new extracellular type solution for lung preservation: "in vitro" comparison with Beltzer, low potassium Dextran and Euro-Collins solutions by means of human lung fibroblasts.

Spaggiari L, Alfieri R, Rusca M, Carbognani P, Urbani S, Petronini P, Cattelani L, Dal Corso HM, Salcuni PF, Borghetti AF, et al.

J Cardiovasc Surg (Torino). 1995 Apr;36(2):185-9.

PMID:
7540610
14.

A novel dextran 40-based preservation solution.

Candinas D, Largiadèr F, Binswanger U, Sutherland DE, Schlumpf R.

Transpl Int. 1996;9(1):32-7.

PMID:
8748408
15.

Lung Preservation With Perfadex or Celsior in Clinical Transplantation: A Retrospective Single-Center Analysis of Outcomes.

Gohrbandt B, Simon AR, Warnecke G, Fischer S, Hagl C, Niehaus A, Gottlieb J, Welte T, Haverich A, Strueber M.

Transplantation. 2015 Sep;99(9):1933-9. doi: 10.1097/TP.0000000000000578.

PMID:
25651311
17.

Impact of donor-recipient race matching on survival after lung transplantation: analysis of over 11,000 patients.

Allen JG, Weiss ES, Merlo CA, Baumgartner WA, Conte JV, Shah AS.

J Heart Lung Transplant. 2009 Oct;28(10):1063-71. doi: 10.1016/j.healun.2009.06.012.

PMID:
19782288
18.
19.

Celsior versus University of Wisconsin preserving solutions for liver transplantation: postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study.

García-Gil FA, Serrano MT, Fuentes-Broto L, Arenas J, García JJ, Güemes A, Bernal V, Campillo A, Sostres C, Araiz JJ, Royo P, Simón MA.

World J Surg. 2011 Jul;35(7):1598-607. doi: 10.1007/s00268-011-1078-7.

PMID:
21487851
20.

Retrograde in situ versus antegrade pulmonary preservation in clinical lung transplantation: a single-centre experience.

Gohrbandt B, Warnecke G, Fischer S, Simon AR, Gottlieb J, Niehaus A, Böthig D, Haverich A, Strueber M.

Eur J Cardiothorac Surg. 2016 Jan;49(1):55-62. doi: 10.1093/ejcts/ezv108.

PMID:
25881588
Items per page

Supplemental Content

Support Center